From USFDA
Ajanta Pharma announced that the Company has received the final approval for Clonidine Hydrochloride Extended Release Tablets from US FDA and the same has been launched in US Market through its wholly owned subsidiary, Ajanta Pharma USA Inc.It is a bioequivalent generic version of Kapvay1 Tablets and company has launched the product in 0.1mg dosage
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)